Tarceva makers warn of liver damage, 2 deaths
9/23/2008
Genentech Inc and OSI Pharmaceuticals have alerted doctors about cases of liver damage among vocation who took the cancer drug Tarceva, U.S. regulators said on Tuesday.
More: - Continued here
Post Comment
Entry 1 of 16100
Last Page | Next Page









